A national generic drug and biosimilar industry group failed to show it will suffer concrete harm under an Illinois drug pricing law, the state’s attorney general argued in response to the group’s revised lawsuit challenging the statute.
The Association for Accessible Medicine’s amended complaint rests on speculative injuries that don’t resolve deficiencies a judge for the US District Court for the Northern District of Illinois identified when dismissing the case in June, Illinois Attorney General Kwame Raoul (D) wrote in his motion to dismiss filed Friday.
AAM first brought its lawsuit in January against the Illinois law, which allows the ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.